Skip to Content
Merck
CN

P0169

Palmityl palmitate

≥99%

Synonym(s):

Cetyl palmitate, Hexadecyl hexadecanoate, Palmitic acid palmityl ester

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
CH3(CH2)14CO2(CH2)15CH3
CAS Number:
Molecular Weight:
480.85
NACRES:
NA.25
PubChem Substance ID:
UNSPSC Code:
12352211
EC Number:
208-736-6
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

PXDJXZJSCPSGGI-UHFFFAOYSA-N

InChI

1S/C32H64O2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-34-32(33)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-31H2,1-2H3

SMILES string

CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC

biological source

synthetic (organic)

assay

≥99%

form

powder

mp

55-56 °C (lit.)

functional group

ester

lipid type

saturated FAs

shipped in

ambient

storage temp.

2-8°C

Quality Level

Related Categories

Storage Class

11 - Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Bruno Sarmento et al.
International journal of nanomedicine, 2(4), 743-749 (2008-01-22)
The aim of this work was to produce and characterize cetyl palmitate-based solid lipid nanoparticles (SLN) containing insulin, and to evaluate the potential of these colloidal carriers for oral administration. SLN were prepared by a modified solvent emulsification-evaporation method based
S Martins et al.
International journal of pharmaceutics, 430(1-2), 216-227 (2012-04-03)
The aim of this work was to develop a systematic analysis of the cellular internalisation mechanism and pathway of solid lipid nanoparticles (SLN) internalisation. To evaluate if SLN show cell uptake and to understand the mechanism of internalisation, four human
Susana M Martins et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 880(1), 100-107 (2011-12-14)
A simple, sensitive and specific high-performance liquid chromatography (HPLC) assay for the quantification of camptothecin (CPT), a potent anticancer candidate, incorporated into solid lipid nanoparticles (SLN) in several rat organs (brain, heart, kidneys liver, lung, spleen) and serum was developed
A Lippacher et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 53(2), 155-160 (2002-03-07)
Aqueous solid lipid nanoparticle (SLN) dispersions with a high lipid content up to 35% and viscous to semisolid consistency were produced by a high pressure homogenization process. Despite their high lipid content and viscosity these dispersions preserved their colloidal size
G Lukowski et al.
International journal of pharmaceutics, 196(2), 201-205 (2000-03-04)
Solid lipid nanoparticles (SLN) as alternative intravenous colloidal drug carriers were produced by high pressure homogenisation of the melted lipid cetylpalmitate. The crystallographic properties of the used cetylpalmitate SLN were characterised by small angle X-ray scattering (SAXS) and X-ray diffraction

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service